Testing the Addition of Tazemetostat to the Immunotherapy Drug, Pembrolizumab (MK-3475), in Advanced Urothelial Carcinoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
GI Innovation, Inc.
Merck Sharp & Dohme LLC
Astellas Pharma Inc
Mayo Clinic
Neonc Technologies, Inc.
Bristol-Myers Squibb
Genmab
Pfizer
Merck Sharp & Dohme LLC